Posted in

Recent News

September is Prostate Cancer Awareness Month

If you are a man between the ages of 55 and 69, September is a good time to schedule a prostate screening, one that includes both a PSA blood test and prostate examination. Consider the numbers: Prostate cancer is the most common genitourinary cancer treated by a urologist and the…

COMPPARE Invited To Participate in Annual PCORI Meeting

Dr. Nancy Mendenhall, COMPPARE Principal Investigator, and Charles Griggs, Minority Engagement Group Coordinator, have been invited to participate in the seventh annual meeting of the Patient-Centered Outcomes Research Institute (PCORI), to be held virtually in November. Dr. Mendenhall and Mr. Griggs will contribute as panelists in a session focused on…

COMPPARE Study Highlighted in Cancer Connections Presentation

On February 17, 2021, Cancer Connections, a UF Monthly Educational & Networking Meeting, presented “COMPPARE Clinical Trial: Protons vs Photons to Treat Prostate Cancer.” Dr. Nancy Mendenhall, M.D., FACR, FASTRO, COMPPARE Principal Investigator, provided an overview of the UF-led national ongoing prostate cancer clinical trial, highlighting the differences between between…

COMPPARE Enrolls 1,000 Patients

The COMPPARE team was pleased to announce on November 13, 2020 that the study had enrolled 1,000 patients, one-third of its 3,000-patient goal. COMPPARE’s partner site, the James M. Slater, MD Proton Treatment & Research Center, Loma Linda, CA, enrolled the 1,000th patient. COMPPARE stands for “A Prospective COMparative Study…

Research and Outcomes for Black Men Are Discussed in Prostate Cancer Webinar

Mr. Charles Griggs and Drs. Nancy Mendenhall and Curtiland Deville participated in “Our Health, Our Voice: Improving Prostate Cancer Outcomes through Participation in Research” on Wednesday, November 4, 2020. The live information session, presented by 100 Black Men of America, Inc., a COMPPARE partner organization, focused on the…

September is Prostate Cancer Awareness Month

If you are a man between the ages of 55 and 69, September is a good time to schedule a prostate screening, one that includes both a PSA blood test and prostate examination. Consider the numbers: Prostate cancer is the most common genitourinary cancer treated by a urologist. Approximately one…

COMPPARE Expands Eligibility Criteria

The 2020 COMPPARE Workshop: Accrual, Monitoring, and Engagement, held in Amelia Island, FL, January 17 – 19, 2020, allowed researchers and patients to cross-pollinate their ideas and help COMPPARE succeed. One important outcome of the meeting, the decision to expand COMPPARE eligibility criteria, was derived from…

COMPPARE Reaches Institutional Milestone

The COMPPARE Coordinating Center is very pleased to announce the activation of all 45 original targeted study sites. The UH Seidman Cancer Center was welcomed on June 1, 2020, for a total 12 new sites and principal investigators added to the team: UH Seidman Cancer Center, Cleveland,…

COMPPARE 2020 Workshop

The Coordinating Center team would like to thank the patient stakeholders, minority engagement group members, site PIs, co-investigators, research coordinators, invited speakers, and other dedicated team members who made the COMPPARE 2020 Workshop a success! Archived conference presentations are now available.

Contact the COMPPARE Team